Once-Weekly and Once-Monthly HIV Meds in the Pipeline: Studies From ICAAC 2012
“Two new HIV drugs in development that show promise for less frequent dosing were previewed at ICAAC 2012 in San Francisco.
One of the drugs, a fusion inhibitor named albuvirtide, could make once-a-week HIV medication a reality.Results from two small Chinese studies demonstrated the general safety and effectiveness of albuvirtide.
The first study followed 54 HIV-infected, treatment-naive individuals in Beijing, all of whom had a viral load above 5,000 copies/mL and a CD4+ cell count above 250 cells/mm3. The group consisted of 39 men and 15 women with a median age of 37.5. Each participant was either treated with a single dose of albuvirtide or a placebo. Two participants discontinued treatment during the study…”
via The Body
13 Notes/ Hide
-
swimslikefish reblogged this from coeternally
-
ohioadvocates reblogged this from projectqueer
-
jack-not-jacque likes this
-
safespacenetwork reblogged this from pozliving
-
torukun1 likes this
-
coeternally reblogged this from projectqueer
-
darklingrising reblogged this from projectqueer
-
thewinterbird likes this
-
randomfandomer likes this
-
projectqueer reblogged this from pozliving
-
pozzypoet reblogged this from pozliving and added:
Something good to look forward to since I have yet to start my meds.
-
pozzypoet likes this
-
raygunssodomyandtheclash likes this
-
apostrophiee likes this
-
pozliving posted this
